FDA Inspection 973204 — CHI Health CUMC - Bergan Mercy
The FDA completed an inspection of CHI Health CUMC - Bergan Mercy on June 1, 2016 in Omaha, NE. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 1, 2016
- Fiscal Year
- 2016
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Omaha, NE (United States)